Pamela Vig is CSO at Mirum Pharmaceuticals, Inc. (MIRM). They have made 6 open-market trades across 1 company since 2019, most recently 2024-06-24.
CIK 0001780069
1 open-market purchase totalling $18K since 2019, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MIRM | 57,965 | $5.6M |
Shares reported on the most recent Form 4, priced at the 2024-06-25 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MIRM | SELL · 10b5-1 | 2024-06-24 | 2024-06-25 | $34.00 | $1.0M | +8.5% | +22.0% | +17.6% |
| MIRM | SELL | 2024-02-02 | 2024-02-05 | $26.19 | $32K | +10.5% | +8.4% | +0.6% |
| MIRM | SELL | 2024-01-08 | 2024-01-09 | $28.03 | $39K | -3.9% | -1.9% | -5.8% |
| MIRM | SELL | 2023-07-03 | 2023-07-05 | $25.65 | $37K | +5.4% | +2.8% | +15.7% |
| MIRM | SELL | 2023-01-09 | 2024-03-18 | $20.62 | $28K | -5.6% | -10.4% | +24.0% |
| MIRM | SELL | 2021-10-01 | 2021-10-01 | $19.26 | $26K | -12.1% | -15.6% | -18.3% |
| MIRM | BUY | 2019-09-06 | 2019-09-10 | $10.97 | $18K | -11.0% | -9.2% | -7.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.